期刊
FRONTIERS IN AGING NEUROSCIENCE
卷 13, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2021.690372
关键词
cholesterol; Alzheimer; ApoE; gliosis; iPSC models
资金
- ZonMW-Memorabel [733050515]
- Alzheimer association Nederland [WE.032019-13]
- Alzheimer Association AARG grant [2019-AARG-643165]
The brain tightly regulates cholesterol levels for physiological function, but excessive accumulation may contribute to Alzheimer's disease. Genetic risk factors associated with cholesterol metabolism may impact AD pathology. Advances in CRISPR/Cas9 gene editing and iPSC technology hold promise for further understanding these mechanisms.
While the central nervous system compromises 2% of our body weight, it harbors up to 25% of the body's cholesterol. Cholesterol levels in the brain are tightly regulated for physiological brain function, but mounting evidence indicates that excessive cholesterol accumulates in Alzheimer's disease (AD), where it may drive AD-associated pathological changes. This seems especially relevant for late-onset AD, as several of the major genetic risk factors are functionally associated with cholesterol metabolism. In this review we discuss the different systems that maintain brain cholesterol metabolism in the healthy brain, and how dysregulation of these processes can lead, or contribute to, Alzheimer's disease. We will also discuss how AD-risk genes might impact cholesterol metabolism and downstream AD pathology. Finally, we will address the major outstanding questions in the field and how recent technical advances in CRISPR/Cas9-gene editing and induced pluripotent stem cell (iPSC)-technology can aid to study these problems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据